Alliance for Regenerative Medicine’s Post

Former FDA Commissioner Scott Gottlieb will headline the 2024 Cell & Gene Meeting on the Mesa in Phoenix, AZ, with a fireside chat on October 7! A champion for cell and gene therapies, Dr. Gottlieb played a pivotal role in adapting the agency to the first wave of cell and gene therapy products. Under his leadership, the FDA advanced new frameworks for the modern, safe, and effective oversight of gene therapies, cell-based regenerative medicines, targeted drugs, and digital health devices. As commissioner, Dr. Gottlieb predicted the FDA would approve 10-20 cell and gene therapy products per year by 2025. We are delighted to welcome Dr. Gottlieb to Phoenix and look forward to hearing his insights about the future of these transformative medicines. Want to catch his fireside chat? Register for the Meeting on the Mesa: https://lnkd.in/gisXTCii View our sponsorship opportunities: https://lnkd.in/euPJKGvX #CGMesa24

Carl Schoellhammer

Partner - Biopharma and Advanced Therapies, DeciBio Consulting; Investor, BioTools Fund; Founder / Director, Suono Bio

2mo

Can't wait to see what the meeting is like on a "new" mesa!

Like
Reply

To view or add a comment, sign in

Explore topics